This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 1124 |
| COVID-19 | 909 |
| CoV-2 | 760 |
| ACE2 | 432 |
| Coronavirus | 153 |
| China | 149 |
| CoV | 124 |
| II | 114 |
| IL-6 | 106 |
| T | 106 |
| ARDS | 101 |
| TNF | 98 |
| Med | 93 |
| Hypotheses | 92 |
| AAT | 92 |
| Wuhan | 91 |
| DOI | 87 |
| sha | 83 |
| Disease | 81 |
| RNA | 79 |
| PTX | 79 |
| TMPRSS2 | 67 |
| α | 64 |
| NAC | 57 |
| East | 54 |
| Covid-19 | 52 |
| BCG | 51 |
| HCQ | 49 |
| CD8 | 49 |
| S | 49 |
| PS | 49 |
| RAS | 48 |
| MERS | 48 |
| HIV | 48 |
| Ang | 48 |
| ATP | 45 |
| EMMPRIN | 43 |
| Health | 43 |
| ICU | 42 |
| CD4 | 42 |
| Asia | 42 |
| ACE | 42 |
| Novel | 42 |
| Italy | 41 |
| HMGB1 | 41 |
| Angiotensin | 40 |
| Cu | 39 |
| Europe | 39 |
| CD33 | 37 |
| GcMAF | 36 |
| NAD | 35 |
| Human | 34 |
| Clinical | 34 |
| MDSC | 33 |
| IFN | 33 |
| A | 33 |
| K | 32 |
| COVID | 31 |
| Etna | 30 |
| DHA | 30 |
| Syndrome | 29 |
| CoV-1 | 29 |
| S1 | 28 |
| Respiratory | 28 |
| Ebola | 28 |
| ABO | 28 |
| Fig | 27 |
| inflammasome | 26 |
| N | 26 |
| ACE-2 | 26 |
| Pentoxifylline | 25 |
| PG | 25 |
| ADAM17 | 25 |
| Germany | 24 |
| B | 24 |
| TMV | 24 |
| New | 24 |
| Spike | 24 |
| VKORC1 | 23 |
| IL-1 | 23 |
| C | 23 |
| rhein | 22 |
| L | 22 |
| HPA | 21 |
| December | 21 |
| Gc | 21 |
| meta | 21 |
| Patients | 21 |
| World | 21 |
| nan | 21 |
| SGP | 20 |
| Lung | 20 |
| RBD | 20 |
| SIRT1 | 20 |
| United | 20 |
| V | 20 |
| κB | 19 |
| À1 | 19 |
| Virus | 19 |
| Treg | 19 |
| Treatment | 19 |
| Siglec-5 | 19 |
| Pneumonia | 19 |
| Neutrophil | 19 |
| Drug | 19 |
| Influenza | 18 |
| CQ | 18 |
| Hydroxychloroquine | 18 |
| IV | 18 |
| IL-8 | 18 |
| LPS | 18 |
| ɑ | 18 |
| γ | 18 |
| NLRP3 | 18 |
| March | 17 |
| 8) | 17 |
| Associated | 17 |
| Association | 17 |
| CMV | 17 |
| HLA | 17 |
| EVALI | 17 |
| Mount | 17 |
| National | 17 |
| Organization | 17 |
| Protein | 17 |
| ROS | 17 |
| TB | 17 |
| UK | 17 |
| NF | 16 |
| COV-2 | 16 |
| DM2 | 16 |
| DNA | 16 |
| Enzyme | 16 |
| Hong | 16 |
| IL-10 | 16 |
| Kong | 16 |
| vivo | 16 |
| Pulmonary | 16 |
| Review | 16 |
| Sicily | 16 |
| States | 16 |
| Study | 16 |
| Th17 | 16 |
| Viral | 16 |
| Infection | 15 |
| Central | 15 |
| Group | 15 |
| Receptor | 15 |
| Pandemic | 15 |
| CD147 | 14 |
| kappaB | 14 |
| doc_id | 14 |
| annexin | 14 |
| US | 14 |
| TLR4 | 14 |
| South | 14 |
| PPAR | 14 |
| Evaluation | 14 |
| Cell | 14 |
| Asians | 14 |
| Characteristics | 13 |
| DIP | 13 |
| Cl | 13 |
| NL63 | 13 |
| Canada | 13 |
| Analysis | 13 |
| Activation | 13 |
| IL-2 | 13 |
| Effect | 13 |
| Spain | 13 |
| Infections | 13 |
| Medical | 13 |
| Middle | 13 |
| PCR | 13 |
| System | 13 |
| Thrombosis | 13 |
| Toronto | 13 |
| Vascular | 13 |
| CoV2 | 12 |
| FH | 12 |
| DBP | 12 |
| HIV-1 | 12 |
| CSF | 12 |
| April | 12 |
| Montelukast | 12 |
| LTBI | 12 |
| NK | 12 |
| NIH | 12 |
| OSCC | 12 |
| Siglecs | 12 |
| X | 12 |
| corona | 12 |
| interleukin-6 | 12 |
| mg | 12 |
| FDA | 11 |
| A2AR | 11 |
| ACE1 | 11 |
| C. | 11 |
| CNS | 11 |
| CT | 11 |
| Care | 11 |
| Chloroquine | 11 |
| D | 11 |
| IFN-1 | 11 |
| Tocilizumab | 11 |
| Immune | 11 |
| J. | 11 |
| January | 11 |
| Japan | 11 |
| P450 | 11 |
| TF | 11 |
| Ibuprofen | 11 |
| York | 11 |
| montelukast | 11 |
| Extracellular | 10 |
| Dihydroxyacetone | 10 |
| Efficacy | 10 |
| Inactivation | 10 |
| H1N1 | 10 |
| IL10 | 10 |
| Cov-2 | 10 |
| S2 | 10 |
| Chinese | 10 |
| COPD | 10 |
| Anti | 10 |
| America | 10 |
| Allium | 10 |
| Administration | 10 |
| Li | 10 |
| Inhibition | 10 |
| perinasal | 10 |
| M. | 10 |
| Staphylococcus | 10 |
| Mycobacterium | 10 |
| hydroxychloroquine | 10 |
| Zn | 10 |
| Willebrand | 10 |
| Stress | 10 |
| intraalveolar | 10 |
| Research | 10 |
| RH | 10 |
| Prevention | 10 |
| Potential | 10 |
| NTD | 10 |
| Report | 10 |
| France | 9 |
| I | 9 |
| HDEF5 | 9 |
| H | 9 |
| Function | 9 |
| Control | 9 |
| EGFR | 9 |
| Cryptococcus | 9 |
| CCIs | 9 |
| Antiviral | 9 |
| Air | 9 |
| L. | 9 |
| IL-6R | 9 |
| Risk | 9 |
| Medicine | 9 |
| azithromycin | 9 |
| Severe | 9 |
| remdesivir | 9 |
| pentoxifylline | 9 |
| mRNA | 9 |
| sativum | 9 |
| VEGF | 9 |
| University | 9 |
| USA | 9 |
| Tregs | 9 |
| Tn | 9 |
| Crohn | 8 |
| JAK | 8 |
| Interactions | 8 |
| Inhibitors | 8 |
| IL1β | 8 |
| IL-1β | 8 |
| Host | 8 |
| Figure | 8 |
| Europeans | 8 |
| Endothelial | 8 |
| DAR | 8 |
| Leydig | 8 |
| Corona | 8 |
| City | 8 |
| Cells | 8 |
| Cardiovascular | 8 |
| CYP1A2 | 8 |
| CD14 | 8 |
| Binding | 8 |
| Autophagy | 8 |
| Angiogenesis | 8 |
| Akt | 8 |
| Activity | 8 |
| Lancet | 8 |
| COVID19 | 8 |
| Liver | 8 |
| Science | 8 |
| MET | 8 |
| VEGFR | 8 |
| Transmission | 8 |
| Therapeutic | 8 |
| Tau | 8 |
| Table | 8 |
| tocilizumab | 8 |
| TLR | 8 |
| Siglec-14 | 8 |
| Siglec | 8 |
| Wang | 8 |
| STAT3 | 8 |
| Rhein | 8 |
| Response | 8 |
| PXR | 8 |
| PAI-1 | 8 |
| North | 8 |
| Natural | 8 |
| Na | 8 |
| NE | 8 |
| Model | 8 |
| SERPIN | 8 |
| Defensins | 7 |
| Copper | 7 |
| Coronaviruses | 7 |
| DKA | 7 |
| HCoV | 7 |
| Distress | 7 |
| Dr. | 7 |
| Evans | 7 |
| Catania | 7 |
| Chen | 7 |
| Acute | 7 |
| Case | 7 |
| Carbohydrate | 7 |
| CYP3A4 | 7 |
| Burnout | 7 |
| Aerosol | 7 |
| ATII | 7 |
| AMPK | 7 |
| ABH | 7 |
| A. | 7 |
| Inhibitor | 7 |
| Hospitalized | 7 |
| Cytokine | 7 |
| Institute | 7 |
| VKA | 7 |
| Korea | 7 |
| von | 7 |
| simplex | 7 |
| monocyte | 7 |
| mevalonate | 7 |
| herpes | 7 |
| gattii | 7 |
| disease-2019 | 7 |
| West | 7 |
| Vero | 7 |
| phosphatidylglycerol | 7 |
| Type | 7 |
| QT | 7 |
| Transmembrane | 7 |
| PMN | 7 |
| Management | 7 |
| Public | 7 |
| RANKL | 7 |
| S. | 7 |
| TLR2 | 7 |
| G | 6 |
| Entry | 6 |
| G. | 6 |
| Global | 6 |
| Hospital | 6 |
| IL-12 | 6 |
| IL-1b | 6 |
| IL-1 | 6 |
| Immunity | 6 |
| IL18 | 6 |
| IL6 | 6 |
| IX | 6 |
| Injury | 6 |
| Interaction | 6 |
| Interleukin-6 | 6 |
| July | 6 |
| Early | 6 |
| K. | 6 |
| Emergency | 6 |
| CD33-related | 6 |
| Domain | 6 |
| Development | 6 |
| Lipid | 6 |
| ALI | 6 |
| Africa | 6 |
| Annexin | 6 |
| BPH | 6 |
| Bavaria | 6 |
| Blood | 6 |
| Bosentan | 6 |
| CD31 | 6 |
| CYP3A11 | 6 |
| Cancer | 6 |
| Cardiac | 6 |
| Cross | 6 |
| Curcumin | 6 |
| D. | 6 |
| DIC | 6 |
| DR | 6 |
| Kinase | 6 |
| OC43 | 6 |
| M | 6 |
| Structural | 6 |
| TGF | 6 |
| TLR7 | 6 |
| Trial | 6 |
| Use | 6 |
| WHO | 6 |
| Zika | 6 |
| airways | 6 |
| alpha-1-antitrypsin | 6 |
| dipyridamole | 6 |
| hyperimmune | 6 |
| lopinavir | 6 |
| lymphopenia | 6 |
| mTOR | 6 |
| pH | 6 |
| pregnane | 6 |
| MAF | 6 |
| virus-2 | 6 |
| Susceptibility | 6 |
| bioaerosol | 6 |
| Storm | 6 |
| Outcomes | 6 |
| Mas | 6 |
| Mechanisms | 6 |
| Renin | 6 |
| Meta | 6 |
| Mice | 6 |
| Mt. | 6 |
| NaOCl | 6 |
| NH | 6 |
| Recognition | 6 |
| PM2.5 | 6 |
| Pathogenesis | 6 |
| Pathway | 6 |
| Protease | 6 |
| Oxidative | 6 |
| Remdesivir | 6 |
| Randomized | 6 |
| Discovery | 5 |
| ELP | 5 |
| ELISA | 5 |
| EGCG | 5 |
| Dysregulation | 5 |
| EC | 5 |
| E. | 5 |
| Dynamics | 5 |
| Emerging | 5 |
| Diseases | 5 |
| Elastase | 5 |
| Hydrogen | 5 |
| Endothelialitis | 5 |
| Factor | 5 |
| Fenofibrate | 5 |
| Fibrosis | 5 |
| First | 5 |
| HIF | 5 |
| IL-17 | 5 |
| IgG | 5 |
| Interferon | 5 |
| International | 5 |
| Delivery | 5 |
| Director | 5 |
| Adipose | 5 |
| David | 5 |
| CRP | 5 |
| Kumar | 5 |
| -1639A | 5 |
| A2 | 5 |
| AIDS | 5 |
| AII | 5 |
| AP-1 | 5 |
| Alpha-1-antitrypsin | 5 |
| Antigenicity | 5 |
| Azithromycin | 5 |
| Bone | 5 |
| CRS | 5 |
| DHT | 5 |
| CTD | 5 |
| CYP2C11 | 5 |
| CYPs | 5 |
| Ca | 5 |
| Calmette | 5 |
| Center | 5 |
| Children | 5 |
| Chronic | 5 |
| Coenzyme | 5 |
| Complex | 5 |
| Jun | 5 |
| Surface | 5 |
| MCP-1 | 5 |
| Wu | 5 |
| Safety | 5 |
| Serum | 5 |
| Statins | 5 |
| Stem | 5 |
| Structure | 5 |
| Studies | 5 |
| Target | 5 |
| Therapy | 5 |
| U.S. | 5 |
| VAP | 5 |
| XII | 5 |
| RJ | 5 |
| bronchoalveolar | 5 |
| globulin | 5 |
| hepatoma | 5 |
| mmol | 5 |
| ritonavir | 5 |
| thrombi | 5 |
| trans | 5 |
| ¼ | 5 |
| þ | 5 |
| MD | 5 |
| Regulator | 5 |
| sialyl | 5 |
| Pseudomonas | 5 |
| NF-B | 5 |
| Maillard | 5 |
| Professor | 5 |
| Malaria | 5 |
| May | 5 |
| Mesenchymal | 5 |
| Metabolism | 5 |
| Molecular | 5 |
| Monochloramine | 5 |
| NADPH | 5 |
| NALP3 | 5 |
| Maslach | 5 |
| NFB | 5 |
| Pathogen | 5 |
| NHS | 5 |
| Plasma | 5 |
| Plasmodium | 5 |
| Pathology | 5 |
| Patient | 5 |
| PM10 | 5 |
| PBS | 5 |
| Ocular | 5 |
| Heart | 4 |
| HMG | 4 |
| H7N9 | 4 |
| H5N1 | 4 |
| H3N2 | 4 |
| Guerin | 4 |
| Gene | 4 |
| GPI | 4 |
| February | 4 |
| GM | 4 |
| Functional | 4 |
| Food | 4 |
| FFP3 | 4 |
| Epstein | 4 |
| Epidemiology | 4 |
| Epidemiological | 4 |
| Hypothesis | 4 |
| Emodin | 4 |
| Hubei | 4 |
| Interval | 4 |
| III | 4 |
| IL-18 | 4 |
| Editorial | 4 |
| Lombardy | 4 |
| Latin | 4 |
| Kingdom | 4 |
| K2 | 4 |
| K1 | 4 |
| Journal | 4 |
| James | 4 |
| JE | 4 |
| Inflammatory | 4 |
| Inflammation | 4 |
| Induction | 4 |
| Indoor | 4 |
| Inc. | 4 |
| Implications | 4 |
| Immunosuppression | 4 |
| IL-5 | 4 |
| Efb | 4 |
| BALB | 4 |
| EG | 4 |
| Beijing | 4 |
| BASIGIN | 4 |
| Australia | 4 |
| Antibodies | 4 |
| AngII | 4 |
| American | 4 |
| Alpha-1 | 4 |
| Agent | 4 |
| Ag | 4 |
| Adenosine | 4 |
| Activities | 4 |
| ATPase | 4 |
| AT1R | 4 |
| AT1 | 4 |
| AB | 4 |
| A.K. | 4 |
| 3a | 4 |
| MBI | 4 |
| Bacillus | 4 |
| Brazil | 4 |
| E6 | 4 |
| C5 | 4 |
| E | 4 |
| Dis | 4 |
| Diacerein | 4 |
| Data | 4 |
| DIILD | 4 |
| DGK | 4 |
| DD | 4 |
| D3 | 4 |
| Covid19 | 4 |
| Changes | 4 |
| Chandrasekaran | 4 |
| Candida | 4 |
| CYP2D6 | 4 |
| CYP1A1 | 4 |
| CD4+T | 4 |
| CD38 | 4 |
| CC | 4 |
| Lyve-1 | 4 |
| Editor | 4 |
| MGP | 4 |
| Workers | 4 |
| Vitro | 4 |
| Vitamin | 4 |
| Vietnam | 4 |
| Ventilation | 4 |
| VTE | 4 |
| Transcriptional | 4 |
| Tissue | 4 |
| Th1 | 4 |
| TNF | 4 |
| TNF- | 4 |
| TIM-1 | 4 |
| Systemic | 4 |
| Survey | 4 |
| Surfactant | 4 |
| State | 4 |
| Species | 4 |
| Society | 4 |
| WT | 4 |
| Xa | 4 |
| Singapore | 4 |
| Zhang | 4 |
| MHC | 4 |
| volcanogenic | 4 |
| sera | 4 |
| selenoprotein | 4 |
| neoformans | 4 |
| microthrombi | 4 |
| lymphatic | 4 |
| key | 4 |
| ivermectin | 4 |
| immunothrombosis | 4 |
| endosomal | 4 |
| cysteinyl | 4 |
| covid-19 | 4 |
| chromosomal | 4 |
| bosentan | 4 |
| acetylcysteine | 4 |
| Zhonghua | 4 |
| Sirtuins | 4 |
| mV | 4 |
| xue | 4 |
| Particle | 4 |
| PPAR | 4 |
| PKC | 4 |
| PAH | 4 |
| P. | 4 |
| Oliveira | 4 |
| OSMF | 4 |
| Nutrition | 4 |
| Nuclear | 4 |
| NFATc1 | 4 |
| NCoV-19 | 4 |
| N. | 4 |
| Monocyte | 4 |
| Mohamed | 4 |
| Messina | 4 |
| Magnesium | 4 |
| Severity | 4 |
| Macrophage | 4 |
| PS+ | 4 |
| Microvascular | 4 |
| Pathogens | 4 |
| Rapid | 4 |
| Series | 4 |
| Pollution | 4 |
| SARS‐CoV‐2 | 4 |
| Robert | 4 |
| Ritonavir | 4 |
| Replication | 4 |
| Region | 4 |
| Sec | 4 |
| Rao | 4 |
| Protocol | 4 |
| Pregnane | 4 |
| Preterm | 4 |
| Radon | 4 |
| Serine | 4 |
| RSV | 4 |
| R. | 4 |
| Q | 4 |
| HBV | 3 |
| Hanoi | 3 |
| FDPs | 3 |
| Features | 3 |
| Fibrinolysis | 3 |
| Fiji | 3 |
| Formulation | 3 |
| Foundation | 3 |
| Free | 3 |
| Functions | 3 |
| GBS | 3 |
| Genetics | 3 |
| Genomewide | 3 |
| Gupta | 3 |
| Gururaj | 3 |
| Extrapulmonary | 3 |
| GSH | 3 |
| Effectiveness | 3 |
| Exposure | 3 |
| ECMO | 3 |
| Disease19 | 3 |
| High | 3 |
| Dose | 3 |
| Dosing | 3 |
| E2 | 3 |
| EBV | 3 |
| EES | 3 |
| Evidence | 3 |
| Eastern | 3 |
| Eduardo | 3 |
| Effects | 3 |
| El | 3 |
| Environmental | 3 |
| Epub | 3 |
| Hepatitis | 3 |
| Interest | 3 |
| Huang | 3 |
| Letter | 3 |
| Ivermectin | 3 |
| JNK | 3 |
| Jan | 3 |
| LMWH | 3 |
| Labor | 3 |
| Laboratory | 3 |
| Leukocyte | 3 |
| Interference | 3 |
| Levels | 3 |
| Lithium | 3 |
| Load | 3 |
| Lombardia | 3 |
| Low | 3 |
| Differences | 3 |
| Involvement | 3 |
| Institutes | 3 |
| Hypomagnesemia | 3 |
| Impact | 3 |
| Hypoxia | 3 |
| I. | 3 |
| IL-21 | 3 |
| IgA | 3 |
| Image | 3 |
| Imaging | 3 |
| Index | 3 |
| Insights | 3 |
| India | 3 |
| Industrial | 3 |
| Infectious | 3 |
| Inflammasome | 3 |
| Innate | 3 |
| Insight | 3 |
| Dipyridamole | 3 |
| Barr | 3 |
| Diao | 3 |
| Diagnosis | 3 |
| Allicin | 3 |
| Alveolar | 3 |
| Alzheimer | 3 |
| Amadori | 3 |
| Ang1 | 3 |
| Antibiotics | 3 |
| Antonio | 3 |
| Associate | 3 |
| August | 3 |
| Autopsy | 3 |
| Axis | 3 |
| BAME | 3 |
| Manifestations | 3 |
| Baseline | 3 |
| Basis | 3 |
| Aged | 3 |
| Age | 3 |
| Adipocytes | 3 |
| ACE2R | 3 |
| -/mice | 3 |
| -ACE2 | 3 |
| 2D | 3 |
| A20 | 3 |
| A5 | 3 |
| ABG | 3 |
| ADAM | 3 |
| Adipocyte | 3 |
| ADE | 3 |
| ADP | 3 |
| AECII | 3 |
| AT(1 | 3 |
| AT1Rs | 3 |
| AZM | 3 |
| Broad | 3 |
| Bronchoscopic | 3 |
| Burkholderia | 3 |
| Cystic | 3 |
| Conditions | 3 |
| CoronaVirus | 3 |
| Coronary | 3 |
| Creactive | 3 |
| Critical | 3 |
| Current | 3 |
| DAD | 3 |
| Comparative | 3 |
| DAG | 3 |
| DC | 3 |
| DEFA | 3 |
| DM | 3 |
| Declaration | 3 |
| Dengue | 3 |
| Comprehensive | 3 |
| Comorbidities | 3 |
| C57BL/6 | 3 |
| COVID-2019 | 3 |
| CA | 3 |
| CDC | 3 |
| COV2 | 3 |
| COVACTA | 3 |
| COVD-19 | 3 |
| COVID-19-induced | 3 |
| CSS | 3 |
| Co | 3 |
| CYP2C9 | 3 |
| Campos | 3 |
| Canon | 3 |
| Cases | 3 |
| Chan | 3 |
| Chemical | 3 |
| MAPK | 3 |
| Adults | 3 |
| Matrix | 3 |
| eastern | 3 |
| administration | 3 |
| allele | 3 |
| alpha | 3 |
| ambroxol | 3 |
| antigen | 3 |
| antiproliferative | 3 |
| budesonide | 3 |
| caspase-1 | 3 |
| caspase-3 | 3 |
| cepacia | 3 |
| chloroquine | 3 |
| cis | 3 |
| cytokinic | 3 |
| defensins | 3 |
| diacerein | 3 |
| Zinc | 3 |
| Zeiss | 3 |
| Young | 3 |
| V. | 3 |
| Testis | 3 |
| Thromboembolic | 3 |
| TnI | 3 |
| Tobacco | 3 |
| Trials | 3 |
| Upregulation | 3 |
| VSV | 3 |
| Yaron | 3 |
| Va | 3 |
| Viruses | 3 |
| Von | 3 |
| Wells | 3 |
| Western | 3 |
| Women | 3 |
| dihydroxyacetone | 3 |
| enterocytes | 3 |
| Technical | 3 |
| heparin | 3 |
| prothrombinase | 3 |
| rd | 3 |
| retrocyclins | 3 |
| rs3865444 | 3 |
| south | 3 |
| tPA | 3 |
| thrombomodulin | 3 |
| yi | 3 |
| zhi | 3 |
| | | 3 |
| ® | 3 |
| Þ | 3 |
| β1 | 3 |
| | 3 |
| Mayoral | 3 |
| protein-1 | 3 |
| protein | 3 |
| plasmin | 3 |
| medRxiv | 3 |
| hepatitis | 3 |
| hypercoagulopathy | 3 |
| inhibitor-1 | 3 |
| interferon | 3 |
| intratracheal | 3 |
| lymphocytopenia | 3 |
| microdroplets | 3 |
| paraventricular | 3 |
| min | 3 |
| monochloramine | 3 |
| multicentre | 3 |
| multiorgan | 3 |
| novo | 3 |
| pandemic | 3 |
| Technology | 3 |
| hyperinflammatory | 3 |
| TMPRSS-2 | 3 |
| Post | 3 |
| Oxidant | 3 |
| PDE | 3 |
| 3 | |
| PE | 3 |
| PEEP | 3 |
| PGC-1α | 3 |
| PH | 3 |
| Paneth | 3 |
| Particulate | 3 |
| Paul | 3 |
| Paulo | 3 |
| Perspective | 3 |
| Peter | 3 |
| Phase | 3 |
| Phosphatidylglycerol | 3 |
| Osaka | 3 |
| Origin | 3 |
| OPG | 3 |
| Modification | 3 |
| Mechanism | 3 |
| THC | 3 |
| Metabolic | 3 |
| Method | 3 |
| MicroCLOTS | 3 |
| Miller | 3 |
| NS7b | 3 |
| Number | 3 |
| NY | 3 |
| Nanoparticle | 3 |
| Nature | 3 |
| Nebulized | 3 |
| Night | 3 |
| Niv | 3 |
| Plasminogen | 3 |
| Orleans | 3 |
| Pregnancy | 3 |
| Roles | 3 |
| SKP2 | 3 |
| SO2 | 3 |
| SOD | 3 |
| Sachin | 3 |
| Saharan | 3 |
| Secondary | 3 |
| Shift | 3 |
| Signal | 3 |
| Sildenafil | 3 |
| Single | 3 |
| Sun | 3 |
| Systematic | 3 |
| Preliminary | 3 |
| São | 3 |
| TGEV | 3 |
| SAR | 3 |
| Scientific | 3 |
| RAT1 | 3 |
| RdRp | 3 |
| RAA | 3 |
| RAAS | 3 |
| RBS | 3 |
| RNAemia | 3 |
| Pérez | 3 |
| RT | 3 |
| Pseudomona | 3 |
| Recommendations | 3 |
| Redox | 3 |
| Relationship | 3 |
| Relative | 3 |
| Reports | 3 |
| Rheum | 3 |
| H. | 2 |
| H7 | 2 |
| HA | 2 |
| Glycerite | 2 |
| HGFR | 2 |
| HIF-1 | 2 |
| Guidance | 2 |
| HIF-1α | 2 |
| Guidelines | 2 |
| Green | 2 |
| Guangzhou | 2 |
| Guangdong | 2 |
| Glucosamine | 2 |
| Gregor | 2 |
| Greenhalgh | 2 |
| Gonçalves | 2 |
| Glycoprotein | 2 |
| HMG-1 | 2 |
| HKU1 | 2 |
| ICUs | 2 |
| Hantoushzadeh | 2 |
| HeLa | 2 |
| IL-7 | 2 |
| Gla | 2 |
| IL)-6 | 2 |
| IIA | 2 |
| ID | 2 |
| IC50 | 2 |
| Hypogonadism | 2 |
| Hydrocortisone | 2 |
| Hybrid | 2 |
| Hussain | 2 |
| Humidity | 2 |
| Humans | 2 |
| Hossein | 2 |
| Holmgren | 2 |
| Hoffmann | 2 |
| Hex | 2 |
| Healthcare | 2 |
| Glucocorticoids | 2 |
| FEV | 2 |
| Germoglio | 2 |
| Faecal | 2 |
| Faults | 2 |
| Fate | 2 |
| Fas | 2 |
| Farias | 2 |
| Farag | 2 |
| Far | 2 |
| Fang | 2 |
| Failure | 2 |
| Factors | 2 |
| George | 2 |
| FEV1 | 2 |
| F. | 2 |
| F | 2 |
| Expression | 2 |
| Experience | 2 |
| Exosurf | 2 |
| Exogenous | 2 |
| IL2 | 2 |
| Fig.1 | 2 |
| Filho | 2 |
| Findings | 2 |
| Fine | 2 |
| Genome | 2 |
| Genetic | 2 |
| General | 2 |
| Gender | 2 |
| GWAS | 2 |
| GR | 2 |
| GISAID | 2 |
| Fusion | 2 |
| Furin | 2 |
| Front | 2 |
| Frequency | 2 |
| Francis | 2 |
| Foxp3 | 2 |
| Fox | 2 |
| Formation | 2 |
| Flu | 2 |
| Flow | 2 |
| IL1 | 2 |
| Maldonado | 2 |
| IL5 | 2 |
| Lima | 2 |
| Luar | 2 |
| Lopinavir | 2 |
| Loop | 2 |
| Long | 2 |
| Liu | 2 |
| Lisofylline | 2 |
| Lipsker | 2 |
| Lin | 2 |
| Like | 2 |
| IL8 | 2 |
| Levi | 2 |
| Leica | 2 |
| Lee | 2 |
| Le(x | 2 |
| LTD4 | 2 |
| LDH | 2 |
| Kinetics | 2 |
| Khan | 2 |
| Luis | 2 |
| Luminex | 2 |
| MIP-2 | 2 |
| MMP-9 | 2 |
| Metalloproteinase | 2 |
| Meplazumab | 2 |
| Mental | 2 |
| Men | 2 |
| Melo | 2 |
| Mediterranean | 2 |
| Mechanical | 2 |
| Masayuki | 2 |
| Martin | 2 |
| Maria | 2 |
| Marburg | 2 |
| European | 2 |
| Main | 2 |
| Madapusi | 2 |
| Maciaczyk | 2 |
| MSC | 2 |
| MRI | 2 |
| Kevin | 2 |
| Kerrigan | 2 |
| Karunasagar | 2 |
| Insulin | 2 |
| Information | 2 |
| Infected | 2 |
| Infasurf | 2 |
| Induced | 2 |
| Increased | 2 |
| Imran | 2 |
| Immunotherapy | 2 |
| Immunology | 2 |
| Immunogenicity | 2 |
| Immunofluorescence | 2 |
| Illness | 2 |
| Ill | 2 |
| Identification | 2 |
| ISARIC | 2 |
| IRF3 | 2 |
| IQR | 2 |
| IP-10 | 2 |
| Inpatient | 2 |
| Intensive | 2 |
| Kappa | 2 |
| Interface | 2 |
| Kajetan | 2 |
| Juszczak | 2 |
| José | 2 |
| Joseph | 2 |
| Jaroslaw | 2 |
| Janus | 2 |
| Janaína | 2 |
| JW | 2 |
| JIS | 2 |
| JAK2 | 2 |
| J | 2 |
| IκBα | 2 |
| Isolates | 2 |
| Investigation | 2 |
| Inventory | 2 |
| Intracellular | 2 |
| Interfere | 2 |
| Examination | 2 |
| Chloramine | 2 |
| Estrogen | 2 |
| Based | 2 |
| Bhanja | 2 |
| Berlin | 2 |
| Bergamo | 2 |
| Beclin1-ubiquitination | 2 |
| Beclin-1 | 2 |
| Bauer | 2 |
| Battle | 2 |
| Basic | 2 |
| Bara | 2 |
| CTL | 2 |
| Balaji | 2 |
| Bakhit | 2 |
| Baker | 2 |
| BSA | 2 |
| BDNF | 2 |
| BD | 2 |
| B3 | 2 |
| B. | 2 |
| Biochemistry | 2 |
| Biology | 2 |
| Bioscience | 2 |
| Biosciences | 2 |
| COVID- | 2 |
| COVI-19 | 2 |
| CO | 2 |
| CD36 | 2 |
| CD26 | 2 |
| CCR5-Δ32 | 2 |
| CCL2 | 2 |
| Burak | 2 |
| Brian | 2 |
| Brew | 2 |
| Brennan | 2 |
| Breakthrough | 2 |
| Bowel | 2 |
| Book | 2 |
| Blockers | 2 |
| Biswas | 2 |
| Biotech | 2 |
| Azhar | 2 |
| Assessment | 2 |
| Arginase-1 | 2 |
| Aerosolized | 2 |
| Adamowicz | 2 |
| Activator | 2 |
| Acetylcysteine | 2 |
| Abstract | 2 |
| AT | 2 |
| AS | 2 |
| AMP | 2 |
| AGs | 2 |
| < | 2 |
| 6pvr2vew | 2 |
| 2D:4D | 2 |
| -dependent | 2 |
| -9 | 2 |
| -80 | 2 |
| -/- | 2 |
| 'S | 2 |
| Micro | 2 |
| Adipokines | 2 |
| Affairs | 2 |
| Areas | 2 |
| Affinity | 2 |
| Area | 2 |
| Application | 2 |
| ApoE | 2 |
| Antitrypsin | 2 |
| Antiphospholipid | 2 |
| Anca | 2 |
| Ana | 2 |
| Amir | 2 |
| Alliin | 2 |
| Alexandru | 2 |
| Alejandro | 2 |
| Aldosterone | 2 |
| Albumin | 2 |
| Ahmet | 2 |
| AhR | 2 |
| Africans | 2 |
| African | 2 |
| CR2 | 2 |
| CYP | 2 |
| Escherichia | 2 |
| Dan | 2 |
| Dexamethasone | 2 |
| Design | 2 |
| Dependent | 2 |
| Department | 2 |
| Defensin | 2 |
| Defense | 2 |
| Deaths | 2 |
| Dear | 2 |
| DOCK | 2 |
| CYP2C19 | 2 |
| DMSO | 2 |
| DIZE | 2 |
| Cytokines | 2 |
| Cytochromes | 2 |
| Cysteinyl | 2 |
| Cynthia | 2 |
| Cupric | 2 |
| CuONPs | 2 |
| Diacylglycerol | 2 |
| Diet | 2 |
| Dilemma | 2 |
| Dirk | 2 |
| Eq | 2 |
| Epigallocatechin | 2 |
| Environment | 2 |
| England | 2 |
| Endothelium | 2 |
| Endotheliopathy | 2 |
| Empiric | 2 |
| Edward | 2 |
| Edanz | 2 |
| ET-1 | 2 |
| EMC | 2 |
| Duffy | 2 |
| Droplets | 2 |
| Droplet | 2 |
| Drewa | 2 |
| Downregulation | 2 |
| Donma | 2 |
| Crossing | 2 |
| Creatine | 2 |
| CpG | 2 |
| Colocalization | 2 |
| Coagulopathy | 2 |
| CoV. | 2 |
| CoA | 2 |
| ClinicalTrials.gov | 2 |
| Clin | 2 |
| Citrobacter | 2 |
| Chilblains | 2 |
| Chemistry | 2 |
| Characterization | 2 |
| Characterisation | 2 |
| Chain | 2 |
| Catalin | 2 |
| Carlsbad | 2 |
| Carlos | 2 |
| Camostat | 2 |
| Caetano | 2 |
| CYP2E1 | 2 |
| Cochrane | 2 |
| Commission | 2 |
| Covid | 2 |
| Committee | 2 |
| Course | 2 |
| Council | 2 |
| Coulombic | 2 |
| Corticosteroids | 2 |
| Corticosteroid | 2 |
| Coronavirus-2 | 2 |
| Coronavirus-19 | 2 |
| Coronavirinae | 2 |
| Coronaviridae | 2 |
| Controlled | 2 |
| Contamination | 2 |
| Consumption | 2 |
| Conjunctivitis | 2 |
| Concern | 2 |
| Complement | 2 |
| Competing | 2 |
| Common | 2 |
| Mevalonate | 2 |
| Arakeri | 2 |
| Microbes | 2 |
| Xue | 2 |
| ZIKV | 2 |
| Z | 2 |
| Yu | 2 |
| Yersinia | 2 |
| Yazici | 2 |
| Yang | 2 |
| Yan | 2 |
| YLn | 2 |
| XI | 2 |
| decreto | 2 |
| Writing | 2 |
| Working | 2 |
| Water | 2 |
| Wards | 2 |
| Wall | 2 |
| W | 2 |
| Volcano | 2 |
| Vishal | 2 |
| Zealand | 2 |
| Zhao | 2 |
| acetylgalactosaminidase | 2 |
| acid | 2 |
| coagulase | 2 |
| cmax | 2 |
| cm | 2 |
| choriomeningitis | 2 |
| chloro | 2 |
| chilblain | 2 |
| calicivirus | 2 |
| bing | 2 |
| bevacizumab | 2 |
| betacoronavirus | 2 |
| b. | 2 |
| antiphospholipid | 2 |
| android | 2 |
| alveolus | 2 |
| airway | 2 |
| ageusia | 2 |
| adenohypophysis | 2 |
| Veterans | 2 |
| Ventilator | 2 |
| Vavougios | 2 |
| Therapies | 2 |
| Th | 2 |
| Terminal | 2 |
| Team | 2 |
| Tao | 2 |
| Tang | 2 |
| Tan | 2 |
| Taiwan | 2 |
| Tactical | 2 |
| TRT | 2 |
| TRB | 2 |
| TIM | 2 |
| TH17 | 2 |
| TGF- | 2 |
| TACE | 2 |
| Systems | 2 |
| Synthesis | 2 |
| Synthase | 2 |
| Thakur | 2 |
| Thodur | 2 |
| Varadarajan | 2 |
| Thrombotic | 2 |
| Valsartan | 2 |
| Vaccine | 2 |
| VIII | 2 |
| VCAM-1 | 2 |
| Urban | 2 |
| Upper | 2 |
| Unit | 2 |
| Unique | 2 |
| Union | 2 |
| Truth | 2 |
| Trends | 2 |
| Treatments | 2 |
| Translational | 2 |
| Tomasz | 2 |
| Toll | 2 |
| Tirschenreuth | 2 |
| Thujaplicin | 2 |
| cyclophilin | 2 |
| desiccates | 2 |
| Support | 2 |
| pyrrolidine | 2 |
| tocotrienol | 2 |
| thromboprophylaxis | 2 |
| tenase | 2 |
| sulfate | 2 |
| sirukumab | 2 |
| sPLA | 2 |
| reninangiotensin | 2 |
| rapamycin | 2 |
| procollagen | 2 |
| dexamethasone | 2 |
| plasmacytoid | 2 |
| phorbol | 2 |
| perforin | 2 |
| oseltamivir | 2 |
| nucleus | 2 |
| nucleocapsid | 2 |
| novaferon | 2 |
| north | 2 |
| torsade | 2 |
| transmembrane | 2 |
| tumorogenesis | 2 |
| uPA | 2 |
| Mitochondria | 2 |
| M | 2 |
| ≥10 | 2 |
| ≤33 | 2 |
| • | 2 |
| μg | 2 |
| θ | 2 |
| β | 2 |
| ° | 2 |
| ~2 | 2 |
| zanamivir | 2 |
| za | 2 |
| www.elsevier.com/locate/mehy | 2 |
| world | 2 |
| west | 2 |
| viroporin | 2 |
| vasoplegia | 2 |
| nonradicalic | 2 |
| nitroso | 2 |
| neuro | 2 |
| hydrochloroquine | 2 |
| https://en-author-services.edanzgroup.com/ac | 2 |
| https:// | 2 |
| health | 2 |
| haemodialysis | 2 |
| gp41 | 2 |
| glioma | 2 |
| gallate | 2 |
| fucose | 2 |
| fluoro | 2 |
| expðÀjtÞ | 2 |
| epigallocatechin | 2 |
| enzyme-2 | 2 |
| doxycycline | 2 |
| doi | 2 |
| dithiocarbamate | 2 |
| disease | 2 |
| dialysate | 2 |
| hyaluronan | 2 |
| hydrolase | 2 |
| nd | 2 |
| hypoxaemia | 2 |
| muscus | 2 |
| monalizumab | 2 |
| midazolam | 2 |
| microvascular | 2 |
| micro | 2 |
| methaemoglobin | 2 |
| mIL-6R | 2 |
| lymphohistiocytosis | 2 |
| lisofylline | 2 |
| laidlawii | 2 |
| lMÞ | 2 |
| kg | 2 |
| keto | 2 |
| journal | 2 |
| intracellulare | 2 |
| influenza | 2 |
| ibuprofenate | 2 |
| Sweden | 2 |
| garlic | 2 |
| Superior | 2 |
| PaO | 2 |
| Pedro | 2 |
| Patil | 2 |
| Pathophysiology | 2 |
| Pathological | 2 |
| Pathogenic | 2 |
| Park | 2 |
| Panel | 2 |
| Palermo | 2 |
| Pa | 2 |
| Preventive | 2 |
| PPARδ | 2 |
| PPARα | 2 |
| PM | 2 |
| PKA | 2 |
| PGE2 | 2 |
| PDT | 2 |
| PD1 | 2 |
| Ozdemir | 2 |
| Peptides | 2 |
| Peroxisome | 2 |
| Perrin | 2 |
| Persistence | 2 |
| Presence | 2 |
| Pregnant | 2 |
| Prediction | 2 |
| Practice | 2 |
| Positive | 2 |
| Po | 2 |
| Plasticity | 2 |
| Pituitary | 2 |
| Physiology | 2 |
| Physiological | 2 |
| Phosphatidylserine | 2 |
| Pharmacologic | 2 |
| Pharmacokinetic | 2 |
| Pharma | 2 |
| PhD | 2 |
| Perspectives | 2 |
| Person | 2 |
| Outbreak | 2 |
| Organ | 2 |
| Oral | 2 |
| Nanjing | 2 |
| NSAIDs | 2 |
| NS8 | 2 |
| NRF2 | 2 |
| NHANES | 2 |
| NFkB | 2 |
| NETosis | 2 |
| NCBI | 2 |
| N95 | 2 |
| Myeloidderived | 2 |
| Mycoplasma | 2 |
| Mutations | 2 |
| Mustafa | 2 |
| Multivalent | 2 |
| Multiple | 2 |
| Sultan | 2 |
| Miyasaka | 2 |
| Models | 2 |
| Nacetylcysteine | 2 |
| Nanomedicine | 2 |
| Operative | 2 |
| Nanoparticles | 2 |
| OpenSAFELY | 2 |
| Onset | 2 |
| Oncology | 2 |
| October | 2 |
| Obesity | 2 |
| ORFs | 2 |
| OPV | 2 |
| OPMD | 2 |
| OA | 2 |
| Null | 2 |
| Norway | 2 |
| Northern | 2 |
| Norovirus | 2 |
| Norooznezhad | 2 |
| Neurological | 2 |
| Network | 2 |
| Netherlands | 2 |
| Present | 2 |
| Open | 2 |
| Primary | 2 |
| Sarode | 2 |
| Sharon | 2 |
| Shanghai | 2 |
| Shamshirsaz | 2 |
| Sex | 2 |
| September | 2 |
| Semen | 2 |
| Sedigheh | 2 |
| Screening | 2 |
| Sarilumab | 2 |
| SDA | 2 |
| Sargan | 2 |
| Saranya | 2 |
| Sandhaus | 2 |
| Salivary | 2 |
| STAT | 2 |
| SLE | 2 |
| SIRS | 2 |
| SIR | 2 |
| Siglec-3 | 2 |
| Silva | 2 |
| Simvastatin | 2 |
| Singlet | 2 |
| Sub | 2 |
| Streptococcus | 2 |
| Stokes | 2 |
| Priming | 2 |
| Steven | 2 |
| Statin | 2 |
| Staff | 2 |
| Stability | 2 |
| Spotlight | 2 |
| Special | 2 |
| Spanish | 2 |
| Spadera | 2 |
| Sodium | 2 |
| Social | 2 |
| Smallpox | 2 |
| Slopes | 2 |
| Sirtuin | 2 |
| SHP-1 | 2 |
| Sherif | 2 |
| SARS-1 | 2 |
| Promotion | 2 |
| RANK | 2 |
| R | 2 |
| Química | 2 |
| PubMed | 2 |
| Prothrombotic | 2 |
| Protective | 2 |
| Prostate | 2 |
| Properties | 2 |
| Prolongation | 2 |
| RCT | 2 |
| Proinflammatory | 2 |
| Progression | 2 |
| Prognostic | 2 |
| SARS)-CoronaVirus | 2 |
| Profile | 2 |
| Product | 2 |
| Products | 2 |
| Prof | 2 |
| RAT2 | 2 |
| Protection | 2 |
| Release | 2 |
| Reduced | 2 |
| SARA | 2 |
| Rhythms | 2 |
| REMAP | 2 |
| Responses | 2 |
| Republic | 2 |
| Renal | 2 |
| Related | 2 |
| Reductase | 2 |
| Ridder | 2 |
| Rapamycin | 2 |
| Recruitment | 2 |
| Reaction | 2 |
| Ratio | 2 |
| Rat | 2 |
| Ras | 2 |
| RORγt | 2 |
| Hepcidin | 1 |
| HepA | 1 |
| HepB | 1 |
| Hazards | 1 |
| HepG2f | 1 |
| HepG2 | 1 |
| Herbert | 1 |
| Heparin | 1 |
| Henshaw | 1 |
| Healy | 1 |
| Heinz | 1 |
| Hemoglobin | 1 |
| Heme | 1 |
| Healing | 1 |
| Hematological | 1 |
| Helsinki | 1 |
| Hekla | 1 |
| Hefner | 1 |
| Heffernan | 1 |
| Heather | 1 |
| Herpes | 1 |
| Hernández | 1 |
| Houyi | 1 |
| Hesary | 1 |
| Homozygous | 1 |
| Huerta | 1 |
| Huaqiang | 1 |
| Hausen | 1 |
| Humanized | 1 |
| HuUPBMCs | 1 |
| HuNoV | 1 |
| Hu-1 | 1 |
| Hu | 1 |
| Hoque | 1 |
| Hongzhi | 1 |
| Holbrook | 1 |
| Hesperetin | 1 |
| Hochi | 1 |
| Ho | 1 |
| Histopathology | 1 |
| Histopathologic | 1 |
| Histologic | 1 |
| Hippocampal | 1 |
| Hippensteel | 1 |
| Himachal | 1 |
| Highly | 1 |
| Hess | 1 |
| Hausman | 1 |
| HF | 1 |
| Hatiboglu | 1 |
| HR | 1 |
| HOCl | 1 |
| HO | 1 |
| HMGB1-specific | 1 |
| HMGB1-mediated | 1 |
| HMGB-1 | 1 |
| HLA−DR | 1 |
| HL55601 | 1 |
| HL109015 | 1 |
| HL105649 | 1 |
| HL071556 | 1 |
| HIFs | 1 |
| HE | 1 |
| HDL | 1 |
| HDAC | 1 |
| HCoV229E | 1 |
| HCoV-22E | 1 |
| HCoV-229E | 1 |
| HCFMUSP | 1 |
| Humoral | 1 |
| HBA1cs | 1 |
| HAsynthase | 1 |
| HOPE | 1 |
| HR2 | 1 |
| Hassan | 1 |
| HRCT | 1 |
| Hashmi | 1 |
| Hasan | 1 |
| Harvard | 1 |
| Harutaka | 1 |
| Harris | 1 |
| Harper | 1 |
| Hapivirins | 1 |
| Hantzsch | 1 |
| Hanjun | 1 |
| Hang | 1 |
| Haichao | 1 |
| Haemostasis | 1 |
| Haematology | 1 |
| Hadjadj | 1 |
| HaCaT | 1 |
| HUVEC | 1 |
| HTLV | 1 |
| HSV-2 | 1 |
| HSV | 1 |
| HRP | 1 |
| HRMS | 1 |
| Humidification | 1 |
| Indicators | 1 |
| Humphreys | 1 |
| Immunodeficiency | 1 |
| Immunostaining | 1 |
| Immunoregulatory | 1 |
| Immunoregulation | 1 |
| Immunopharmacological | 1 |
| Immunopathology | 1 |
| Immunopathological | 1 |
| Immunomodulatory | 1 |
| Immunomodulation | 1 |
| Immunologic | 1 |
| Immunohistochemical | 1 |
| Immuno | 1 |
| Huntington | 1 |
| Immunization | 1 |
| Immediate-244 | 1 |
| Imidazole | 1 |
| Imai | 1 |
| Illustration | 1 |
| Illinois | 1 |
| Iinstillation | 1 |
| IgM | 1 |
| IgA. | 1 |
| Ife | 1 |
| Immunothrombosis | 1 |
| Implication | 1 |
| Importance | 1 |
| Important | 1 |
| HAb18 | 1 |
| Integrative | 1 |
| IntechOpen | 1 |
| Instrumental | 1 |
| Innte | 1 |
| Injuries | 1 |
| Initial | 1 |
| Inhibitor-1 | 1 |
| Informative | 1 |
| Infliximab | 1 |
| Inflammageing | 1 |
| Indústria | 1 |
| Inducible | 1 |
| Inducer | 1 |
| Indrani | 1 |
| Indo | 1 |
| Individual | 1 |
| Indications | 1 |
| Indian | 1 |
| Inappropriate | 1 |
| Improve | 1 |
| Ideal | 1 |
| Iddya | 1 |
| Iba | 1 |
| IFA | 1 |
| IDO | 1 |
| IDF | 1 |
| ICP | 1 |
| ICAM-1 | 1 |
| IBD | 1 |
| IAP | 1 |
| IA2 | 1 |
| Hypoxemia | 1 |
| Hypovitaminosis | 1 |
| Hypothalamic | 1 |
| Hypochlorous | 1 |
| Hypochlorite | 1 |
| Hypertension | 1 |
| Hyperimmune | 1 |
| Hypercoagulation | 1 |
| Hypercoagulability | 1 |
| Hyperbaric | 1 |
| Hydrolysis | 1 |
| Hydrogels | 1 |
| Hussein | 1 |
| Hurtado | 1 |
| IE | 1 |
| IFITM3 | 1 |
| IVs | 1 |
| IFN)-α | 1 |
| ISTH | 1 |
| ISO | 1 |
| IRB | 1 |
| IPV | 1 |
| INTRODUCTION | 1 |
| INTEREST | 1 |
| IMD | 1 |
| IL6R | 1 |
| IL4 | 1 |
| IL1-β | 1 |
| IL-4 | 1 |
| IL-38 | 1 |
| IL-37 | 1 |
| IL-33 | 1 |
| IL-2R | 1 |
| IL-1 | 1 |
| IL-1α | 1 |
| IL-1ra | 1 |
| IL-1-induced | 1 |
| IIIA3 | 1 |
| IFNα | 1 |
| HAb18G | 1 |
| FY*O | 1 |
| HAS2 | 1 |
| Forecasting | 1 |
| Force | 1 |
| Foot | 1 |
| Follow | 1 |
| Focus | 1 |
| Fluticasone | 1 |
| Flushing | 1 |
| Fluid | 1 |
| Florentina | 1 |
| Flaviviruses | 1 |
| Flash | 1 |
| Fitzgerald | 1 |
| Fistulas | 1 |
| Fischer | 1 |
| Fiona | 1 |
| Fig.2 | 1 |
| Fibrin(ogen)-alpha | 1 |
| Fibrate | 1 |
| Ferret | 1 |
| Fenton | 1 |
| Feline | 1 |
| Fedratinib | 1 |
| Forecast | 1 |
| Formulary | 1 |
| Fecal | 1 |
| Forner | 1 |
| Future | 1 |
| Fungicidal | 1 |
| Funding | 1 |
| Fundamentals | 1 |
| Functionalized | 1 |
| Fucosyltransferase | 1 |
| Frontline | 1 |
| Frontiers | 1 |
| Frontera | 1 |
| Frithiof | 1 |
| Freudenberger | 1 |
| Frequencies | 1 |
| Frenzel | 1 |
| Freed | 1 |
| Francisco | 1 |
| Frame-8b | 1 |
| Frame-3a | 1 |
| Foxp3(+ | 1 |
| Foxo1 | 1 |
| FoxP3(+ | 1 |
| Fourier | 1 |
| Federation | 1 |
| Fe | 1 |
| G.B. | 1 |
| FGB | 1 |
| FDR | 1 |
| FCN1 | 1 |
| FAPESP | 1 |
| FAO | 1 |
| FACG | 1 |
| F3 | 1 |
| F1 | 1 |
| Eye | 1 |
| Extreme | 1 |
| Extensive | 1 |
| Expert | 1 |
| Expansion | 1 |
| Exercise | 1 |
| Executive | 1 |
| Exacerbations | 1 |
| Evasion | 1 |
| Evaporation | 1 |
| Evali | 1 |
| Eucalyptus | 1 |
| Euan | 1 |
| Ethnic | 1 |
| FGA | 1 |
| FGG | 1 |
| Fazal | 1 |
| FGL2 | 1 |
| Fatty | 1 |
| Fatih | 1 |
| Farzad | 1 |
| Farragher | 1 |
| Farmacêutica | 1 |
| Farid | 1 |
| Family | 1 |
| False | 1 |
| Faiq | 1 |
| Fahrenkopf | 1 |
| Faculty | 1 |
| Factor-B | 1 |
| Facilities | 1 |
| Fabbrocini | 1 |
| Interferon(IFN | 1 |
| FVC | 1 |
| FUT1 | 1 |
| FURIN | 1 |
| FOXP3 | 1 |
| FLC-4 | 1 |
| FK | 1 |
| G)-actin | 1 |
| G614 | 1 |
| H3 | 1 |
| Goz | 1 |
| Goren | 1 |
| Goodie | 1 |
| Good | 1 |
| Gonzales | 1 |
| Gondivkar | 1 |
| Gomar | 1 |
| Golgi | 1 |
| Gokhan | 1 |
| Goel | 1 |
| God | 1 |
| Glycyrrhizin | 1 |
| Glycosylphosphatidylinositol | 1 |
| Glyconanoparticles | 1 |
| Glycans | 1 |
| Glutathione | 1 |
| Glutaryl | 1 |
| Glucose-6-phosphate | 1 |
| Glucose | 1 |
| Glucocorticoid | 1 |
| Glucan | 1 |
| Globe | 1 |
| Government | 1 |
| Gp120 | 1 |
| Gingival | 1 |
| Gram | 1 |
| H2O2 | 1 |
| H+L | 1 |
| H(2)O(2 | 1 |
| Gómez | 1 |
| Guérin | 1 |
| Guoqian | 1 |
| Guo | 1 |
| Guerrini | 1 |
| Guanosine | 1 |
| Guangfu | 1 |
| Grundy | 1 |
| Growth | 1 |
| Groups | 1 |
| Groot | 1 |
| Grimmer | 1 |
| Griess | 1 |
| Greaves | 1 |
| Graziana | 1 |
| Grayck | 1 |
| GraphPad | 1 |
| Grant | 1 |
| Gisela | 1 |
| Gilead | 1 |
| GALT | 1 |
| Garcinoic | 1 |
| Gaoran | 1 |
| Gan | 1 |
| Galway | 1 |
| Gallo | 1 |
| Gadbail | 1 |
| Gabrin | 1 |
| Gabriella | 1 |
| Gabriel | 1 |
| GTPases | 1 |
| GSEA | 1 |
| GRECCO-19 | 1 |
| GPs | 1 |
| GMP | 1 |
| GMM | 1 |
| GM063075 | 1 |
| GLUT1 | 1 |
| GIS | 1 |
| GI | 1 |
| GGT | 1 |
| GDP | 1 |
| GC | 1 |
| Garcia | 1 |
| García | 1 |
| Giarre | 1 |
| Gargi | 1 |
| Giampaolo | 1 |
| Ghiaty | 1 |
| Ghana | 1 |
| Georgius | 1 |
| Georg | 1 |
| Genus | 1 |
| Genova | 1 |
| Genomic | 1 |
| Genomes | 1 |
| Geng | 1 |
| Geneva | 1 |
| Genesis | 1 |
| Generalized | 1 |
| Genebank | 1 |
| GenBank | 1 |
| Ge | 1 |
| Gavin | 1 |
| Gaurav | 1 |
| Gastrointestinal | 1 |
| Gastroenteritis | 1 |
| Garlic | 1 |
| Intellectual | 1 |
| Leucine | 1 |
| Interferons | 1 |
| Mahros | 1 |
| Map | 1 |
| Manual | 1 |
| Manku | 1 |
| Mani | 1 |
| Manenti | 1 |
| Mandi | 1 |
| Man | 1 |
| Maloney | 1 |
| Mallick | 1 |
| Mall | 1 |
| Mahoney | 1 |
| Losses | 1 |
| Mahnaz | 1 |
| Mahmoud | 1 |
| Mahmood | 1 |
| Maheswari | 1 |
| Magro | 1 |
| Magnetic | 1 |
| Maddalena | 1 |
| Macrophages | 1 |
| Macrolides | 1 |
| Mackaness | 1 |
| Maps | 1 |
| Marcelo | 1 |
| Marcus | 1 |
| Marie | 1 |
| Measurement | 1 |
| McSorley | 1 |
| Mazid | 1 |
| Maya | 1 |
| Maurice | 1 |
| Matthay | 1 |
| Matter | 1 |
| Matteen | 1 |
| Matias | 1 |
| Mathieu | 1 |
| Maternal | 1 |
| Master | 1 |
| Massad | 1 |
| Mass | 1 |
| Mash | 1 |
| Mascone | 1 |
| María | 1 |
| Martini | 1 |
| Marr | 1 |
| Mario | 1 |
| Marik | 1 |
| MacKman | 1 |
| Mac-1 | 1 |
| MV | 1 |
| MAPKs | 1 |
| MAMPS | 1 |
| MA15 | 1 |
| M6 | 1 |
| M.K. | 1 |
| M.A.F. | 1 |
| Lyu | 1 |
| Lytic | 1 |
| Lysosomal | 1 |
| Lymphoid | 1 |
| Lymphocytes | 1 |
| Luzon | 1 |
| Luoma | 1 |
| Luo | 1 |
| Lumbardy | 1 |
| Luiz | 1 |
| Lucrezia | 1 |
| Luca | 1 |
| Ltda | 1 |
| Ltd. | 1 |
| Loza | 1 |
| Loyola | 1 |
| MAPK- | 1 |
| MARK | 1 |
| MTT | 1 |
| MAS | 1 |
| MR | 1 |
| MPSV | 1 |
| MPO | 1 |
| MOI | 1 |
| MMR | 1 |
| MMP-3 | 1 |
| MMP-1 | 1 |
| ML | 1 |
| MKN45 | 1 |
| MK-7 | 1 |
| MK-2206 | 1 |
| MIP1α | 1 |
| ME | 1 |
| MDCK | 1 |
| MD-2 | 1 |
| MCT4 | 1 |
| MCT-4 | 1 |
| MCT-1 | 1 |
| MCSF | 1 |
| MCP1 | 1 |
| MAVS | 1 |
| Mechanistically | 1 |
| Mediated | 1 |
| Medscape | 1 |
| Multifaceted | 1 |
| Muhammad | 1 |
| Mufti | 1 |
| Mufson | 1 |
| Mudi | 1 |
| Ms. | 1 |
| Mpro | 1 |
| Mowerer | 1 |
| Movement | 1 |
| Mouse | 1 |
| Most | 1 |
| Mossel | 1 |
| Mosquito | 1 |
| Mosaic | 1 |
| Mortem | 1 |
| Mortality | 1 |
| Morning | 1 |
| Moore | 1 |
| Monteil | 1 |
| Monosodium | 1 |
| Monolayers | 1 |
| Monolayer | 1 |
| Multicenter | 1 |
| Multipotent | 1 |
| Mongolia | 1 |
| Multiscale | 1 |
| NC | 1 |
| NASH | 1 |
| NADP+/NADPH | 1 |
| NADP | 1 |
| NADH | 1 |
| NAD+/NADH | 1 |
| NAD+ | 1 |
| NAD(P)H | 1 |
| NACHT | 1 |
| N282 | 1 |
| N1098 | 1 |
| Myopathy | 1 |
| Myeloperoxidase | 1 |
| Myeloid | 1 |
| Myanmar | 1 |
| Muñoz | 1 |
| Murray | 1 |
| Murine | 1 |
| Murch | 1 |
| Muneeb | 1 |
| Mundkinajeddu | 1 |
| Monitoring | 1 |
| Moment | 1 |
| Meenakshisundaram | 1 |
| Microenvironment | 1 |
| Microcapsules | 1 |
| Microbicidal | 1 |
| Miao | 1 |
| Mexico | 1 |
| Metin | 1 |
| Metastatic | 1 |
| Metamodels | 1 |
| Metaanalysis | 1 |
| Met | 1 |
| Mesenteric | 1 |
| Merit | 1 |
| Merck | 1 |
| Menkes | 1 |
| Memory | 1 |
| Membrane | 1 |
| Members | 1 |
| Melanoma | 1 |
| Mejía | 1 |
| Mehta | 1 |
| Mehraban | 1 |
| Meenu | 1 |
| Microciona | 1 |
| Microparticles | 1 |
| Molecules | 1 |
| Micropractices | 1 |
| Molecule | 1 |
| Mohammad | 1 |
| Modulated | 1 |
| Modular | 1 |
| Modificaiton | 1 |
| Modelling | 1 |
| Moachon | 1 |
| Mitzie | 1 |
| Mitogen | 1 |
| Mitf | 1 |
| Mishra | 1 |
| Mirai | 1 |
| Minority | 1 |
| Minn | 1 |
| Ministry | 1 |
| Minetti | 1 |
| Milan | 1 |
| Mike | 1 |
| Mihalcioiu | 1 |
| Mihai | 1 |
| Microthrombosis | 1 |
| Lovastatin | 1 |
| Loss | 1 |
| Interim | 1 |
| Jorge | 1 |
| K.K. | 1 |
| K+ | 1 |
| Jyothsna | 1 |
| Junin | 1 |
| June | 1 |
| Jukic | 1 |
| Juan | 1 |
| Jr | 1 |
| Joyce | 1 |
| Joshua | 1 |
| Jona | 1 |
| Loredana | 1 |
| John | 1 |
| Jnk | 1 |
| Jinglu | 1 |
| Jing | 1 |
| Jin | 1 |
| Jianhua | 1 |
| Jiangsu | 1 |
| Jiajia | 1 |
| Jezek | 1 |
| Jessica | 1 |
| KDA | 1 |
| Kadi | 1 |
| Kaka | 1 |
| Kakodkar | 1 |
| Khanavi | 1 |
| Khalil | 1 |
| Key | 1 |
| Ketonuria | 1 |
| Keratin | 1 |
| Kentucky | 1 |
| Kennedy | 1 |
| Kenedy | 1 |
| Keith | 1 |
| Kearns | 1 |
| Kavanagh | 1 |
| Kaur | 1 |
| Katoh | 1 |
| Karouta | 1 |
| Karlman | 1 |
| Karim | 1 |
| Karaahmet | 1 |
| Kara | 1 |
| Kant | 1 |
| Kamla | 1 |
| Kamal | 1 |
| Jerome | 1 |
| Jenner | 1 |
| Javor | 1 |
| Isabela | 1 |
| Irvine | 1 |
| Iron | 1 |
| Irf-3 | 1 |
| Ireland | 1 |
| Iran | 1 |
| Ionizing | 1 |
| Ionian | 1 |
| Iodination | 1 |
| IoRestoaCasa | 1 |
| Invitrogen | 1 |
| Investigative | 1 |
| Intubation | 1 |
| Intravenous | 1 |
| Intratracheal | 1 |
| Intima | 1 |
| Interwoven | 1 |
| Interventions | 1 |
| Intervention | 1 |
| Interstitial | 1 |
| Interleukin-1β | 1 |
| Interleukin | 1 |
| Irwin | 1 |
| Islets | 1 |
| Janssen | 1 |
| Isolated | 1 |
| Jakob | 1 |
| Jain | 1 |
| Jaime | 1 |
| Jae | 1 |
| Jadhav | 1 |
| Jacota | 1 |
| JUN | 1 |
| JNK1/2 | 1 |
| JAKs | 1 |
| JAK/ | 1 |
| JACC | 1 |
| J.E. | 1 |
| IB | 1 |
| Ivan | 1 |
| Iupac | 1 |
| Italians | 1 |
| Italian | 1 |
| Italia | 1 |
| Istitvto | 1 |
| Israel | 1 |
| Isolation | 1 |
| Khawaja | 1 |
| Khitan | 1 |
| Khosla | 1 |
| Lifestyle | 1 |
| Library | 1 |
| Liang | 1 |
| Liability | 1 |
| Lewis | 1 |
| Level | 1 |
| Leukotriene | 1 |
| Erythrocytosis | 1 |
| Leu | 1 |
| Lethal | 1 |
| Leptin | 1 |
| Lepique | 1 |
| LepR. | 1 |
| LepR | 1 |
| Leone | 1 |
| Lens | 1 |
| Legionnaires | 1 |
| Lecture | 1 |
| Leavitt | 1 |
| Lazzarino | 1 |
| Lazos | 1 |
| Law | 1 |
| Life | 1 |
| Likert | 1 |
| Latent | 1 |
| Lim | 1 |
| Lopez | 1 |
| Longevity | 1 |
| London | 1 |
| Lodigiani | 1 |
| Lodi | 1 |
| Localization | 1 |
| Lmethionine | 1 |
| Llicorice | 1 |
| Literature | 1 |
| Listeria | 1 |
| Liquids | 1 |
| Lippi | 1 |
| Lipoid | 1 |
| Lipids | 1 |
| Lipemic | 1 |
| Linear | 1 |
| Line | 1 |
| Linchpin | 1 |
| Linactants | 1 |
| Linactant | 1 |
| Limited | 1 |
| Laura | 1 |
| Large | 1 |
| Kidney | 1 |
| Kv3.4 | 1 |
| Kupffer | 1 |
| Kumari | 1 |
| Kulshrestha | 1 |
| Kulandhasamy | 1 |
| Kuebler | 1 |
| Krishnan | 1 |
| Koreans | 1 |
| Konstan | 1 |
| Konrad | 1 |
| Kokn | 1 |
| Kockelman | 1 |
| Kocaman | 1 |
| Kobe | 1 |
| Knowledge | 1 |
| Knockout | 1 |
| Klompas | 1 |
| Klok | 1 |
| Klimke | 1 |
| Kinlen | 1 |
| Kin | 1 |
| Kim | 1 |
| Kv1.1 | 1 |
| LAV | 1 |
| Lara | 1 |
| LBT | 1 |
| Laos | 1 |
| Lanzarotta | 1 |
| Langmuir | 1 |
| Langerhans | 1 |
| Lalani | 1 |
| Laguna | 1 |
| Lactobacillus | 1 |
| Lack | 1 |
| Label | 1 |
| La | 1 |
| LTE4 | 1 |
| LTC4 | 1 |
| LSM710 | 1 |
| LS | 1 |
| LRR | 1 |
| LL-37 | 1 |
| LITERATURE | 1 |
| LIM01 | 1 |
| LIJ | 1 |
| LDLs | 1 |
| LDL | 1 |
| Esquinas | 1 |
| DMI4000B | 1 |
| Eruptive | 1 |
| Aziz | 1 |
| BMI | 1 |
| BCL2L1 | 1 |
| BC | 1 |
| BBB | 1 |
| BB | 1 |
| BAL | 1 |
| B19 | 1 |
| B.W. | 1 |
| B*46:01 | 1 |
| B*15:03 | 1 |
| Ayman | 1 |
| CCR6 | 1 |
| Aya | 1 |
| Award | 1 |
| Aveolar | 1 |
| Autoregulation | 1 |
| Autopsies | 1 |
| Autoimmunity | 1 |
| Autoimmune | 1 |